Table 1.
Clinical Characteristics of Surgically Enucleated Glaucoma Eyes
| Patient | Age/Sex | Glaucoma type | IOPmax. | C/D ratio | Medication | Ocular surgery |
|---|---|---|---|---|---|---|
| 1. F.H. (L) | 81/F | SOAG, PEX | 36 | 1.0 | Travoprost | None |
| Brinzolamide | ||||||
| 2. F.S. (R) | 77/M | SOAG, PEX | 45 | 1.0 | Timolol | Filtration surgery |
| Brimonidine | ||||||
| 3. H.W. (R) | 77/M | SOAG, PEX | 56 | 1.0 | Latanoprost | Laser trabeculoplasty |
| Timolol, Dipivefrin | ||||||
| 4. E.D. (L) | 80/F | SOAG, PEX | 42 | 1.0 | Latanoprost | Filtration surgery |
| Timolol | ||||||
| 5. L.F. (R) | 87/F | POAG | 35 | 1.0 | Timolol | Filtration surgery |
| Pilocarpine | ||||||
| 6. H.G. (R) | 68/M | POAG | 48 | 1.0 | Pilocarpin | Laser trabeculoplasty |
| Carbachol | ||||||
| 7. K.H. (L) | 75/F | POAG | 26 | 1.0 | Timolol | Cataract surgery |
| 8. M.F. (R) | 86/F | ACG, PEX | 40 | 1.0 | Timolol | None |
| 9. F.S. (L) | 85/F | ACG, PEX | 42 | 0.95 | None | None |
| 10. N.P. (R) | 79/M | ACG, PEX | 40 | 0.95 | None | None |
| 11. J.D. (R) | 80/M | ACG, CRVO | 56 | 1.0 | Dorzolamide | None |
| Dipivefrine | ||||||
| 12. L.H. (L) | 84/F | ACG, CRVO | 38 | 1.0 | Latanoprost | Cataract surgery |
| Brimonidine | ||||||
| 13. B.E. (R) | 90/F | ACG, CRVO | 52 | 1.0 | None | Cataract surgery |
| 14. C.H. (L) | 76/F | ACG, CRVO | 40 | 0.95 | None | None |
F, female; M, male; R, right eye; L, left eye; ACG, angle-closure glaucoma; CRVO, central retinal vein occlusion; OAG, open-angle glaucoma; PEX, pseudoexfoliation; POAG, primary open-angle glaucoma; SOAG, secondary open-angle glaucoma.